Monthly subscriptions are coming soon.Explore 15% savings
AccountBag
ULTR-PW-10MGResearch material
Ultra-RT
Defined materials. Documented research.Product record

Conceptual scientific graphic. Refer to the product and lot record for identity and analytical results.

Find COA / lot documentation

Ultra-RT Ultratrutide™

$75.00

Ultra-RT Ultratrutide™ is an advanced experimental quad-agonist peptide developed for metabolic pathway research, combining GLP-1, GIP, Glucagon, and Ghrelin receptor activity into a single innovative research compound designed to explore body composition, energy utilization, and lean tissue signaling pathways.

  • Advanced quad-agonist targeting four metabolic receptor pathways
  • Combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity
  • Designed for body composition and metabolic pathway research
  • Supports investigation of lean tissue signaling mechanisms
  • Innovative next-generation research peptide architecture

Monthly plan $63.75/ month

Monthly subscriptions are coming soon. See plan details.

Out of stock

SKU: ULTR-PW-10MG Categories: , , , , , , Tag: Brand:

Description

Ultra-RT Ultratrutide™ – Advanced Quad-Agonist Peptide for Metabolic Pathway Research

Ultra-RT Ultratrutide™ is an advanced quad-agonist peptide built for metabolic pathway research. It combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity into one research compound. As a result, labs can study several metabolic and hormone pathways at the same time.

Because of this multi-pathway design, researchers can explore energy use, nutrient balance, metabolic control, and lean tissue signaling in one model.

In addition, Ultra-RT Ultratrutide™ goes beyond standard incretin-based compounds by adding Ghrelin receptor activity. Therefore, it gives researchers a broader way to study how the body balances energy use and tissue support during metabolic changes.

Mechanisms of Action

GLP-1 Receptor Activity

GLP-1 receptor activity supports research into satiety signals, glycemic balance, and metabolic control.

GIP Receptor Activity

Likewise, GIP receptor activity helps researchers study insulin signaling, nutrient use, and metabolic efficiency.

Glucagon Receptor Activity

In addition, Glucagon receptor activity allows for research into thermogenesis, liver energy output, and fat metabolism pathways.

Ghrelin Receptor Activity

Finally, Ghrelin receptor agonism targets GHS-R1a pathways and supports research into growth hormone signaling and lean tissue support.

Research Applications

Researchers often use this quad-agonist peptide in studies involving:

  • Multi-pathway metabolic optimization
  • Energy use and nutrient balance
  • Lean tissue signaling during caloric restriction
  • Body composition pathway analysis
  • Hormone response during metabolic shifts

Why Researchers Choose This Quad-Agonist Peptide

Most traditional metabolic research compounds focus only on appetite and glucose pathways. However, Ultra-RT Ultratrutide™ adds Ghrelin receptor activity for a broader research profile.

Because of this added pathway, researchers can study metabolic, anabolic, and recovery-related signaling in one compound.

Overall, Ultra-RT Ultratrutide™ offers labs a next-generation tool for advanced metabolic pathway research.

Research Use Notice

Ultra-RT Ultratrutide™ is intended strictly for laboratory research and analytical purposes only. It is not for human or veterinary use.

Reviews

There are no reviews yet.

Be the first to review “Ultra-RT Ultratrutide™”

Your email address will not be published. Required fields are marked *

What is Ultra-RT Ultratrutide™?

Ultra-RT Ultratrutide™ is an experimental quad-agonist peptide developed for advanced metabolic pathway research. It combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity into a single research compound.

What makes Ultra-RT Ultratrutide™ different from other metabolic research peptides?

Unlike traditional incretin-based compounds, Ultra-RT Ultratrutide™ incorporates four receptor pathways rather than one or two, allowing researchers to study a broader range of metabolic and hormonal interactions.

Which receptors does Ultra-RT Ultratrutide™ target?

Ultra-RT Ultratrutide™ is designed to target GLP-1, GIP, Glucagon, and Ghrelin receptors for multi-pathway metabolic research applications.

What research applications is Ultra-RT Ultratrutide™ commonly used for?

Researchers often utilize Ultra-RT Ultratrutide™ in studies involving metabolic regulation, nutrient partitioning, energy expenditure, body composition analysis, and lean tissue signaling.

Why is Ghrelin receptor activity included in Ultra-RT Ultratrutide™?

The Ghrelin receptor component allows researchers to investigate growth hormone and lean tissue signaling pathways alongside traditional metabolic receptor activity.

Is Ultra-RT Ultratrutide™ intended for human use?

No. Ultra-RT Ultratrutide™ is intended strictly for laboratory research and analytical purposes only and is not for human or veterinary use.

Related products